Charles Kozierok
Elite Member
Pretty amazing stuff:
Also nice to see that they were not held up by bureaucratic red tape:
"They had to do CPR on him every day," said April Gionfriddo, Kaiba's mother, who later found out her son had a rare obstruction in his lungs called bronchial malacia. "I didn't think he was going to leave the hospital alive."
With hopes dimming that Kaiba would survive, doctors tried the medical equivalent of a "Hail Mary" pass. Using an experimental technique never before tried on a human, they created a splint made out of biological material that effectively carved a path through Kaiba's blocked airway.
...
The next big step was getting a CT scan of Kaiba's lungs so that the splint could be fitted to his organs' exact dimensions. Hollister used the results of the scan to generate a computer model of the splint.
The model was fed into a 3-D printer that can engineer structures using a powder called polycaprolactone, or PCL.
...
Green then took the splint, measuring just a few centimeters long and 8 millimeters wide, and surgically attached it to Kaiba's collapsed bronchus. It was only moments before he saw the results.
"When the stitches were put in, we started seeing the lung inflate and deflate," Green said. "It was so fabulous. There were people in the operating room cheering."
...
The splint will take three years to degrade, and in the meantime, Kaiba's lung should continue to develop normally, said Green.
Also nice to see that they were not held up by bureaucratic red tape:
Green, who has been practicing for two decades, and a UM colleague, biomedical engineer Scott Hollister, had been working for years toward a clinical trial to test the splint in children with pulmonary issues when they got a phone call from a physician in Ohio who was aware of their research.
"He said, 'I've got a child who needs (a splint) now,' " referring to Kaiba, said Green. "He said that this child is not going to live unless something is done."
Green and Hollister got emergency clearance from their hospital and the Food and Drug Administration to try the experimental treatment -- which had been used only on animals -- on Kaiba.